Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations

Summary
Organism
Homo sapiens (human)
Reactome
R-HSA-9670615
PubChem
R-HSA-9670615
Description
  • Many tumors that are positive for markers of alternative lengthening of telomeres (ALT) harbor loss-of-function mutations in the ATRX gene, encoding a chromatin remodeling protein ATRX. ATRX is thought to act together with DAXX and histone H3F3A to inhibit DNA recombination at telomere ends. For review, please refer to Heaphy et al. 2011, Gocha et al. 2014, Pickett and Reddel 2015, Amorim et al. 2016.
Click on a node on the pathway to see its details. Glycoproteins are marked with a glycoprotein icon in their name.
Displaying all 2 entries
UniProt ID Protein Name Gene Symbol Pathway Viewer
P46100 Transcriptional regulator ATRX
  • ATRX
  • RAD54L
  • XH2
view
Q9UER7 Death domain-associated protein 6
  • BING2
  • DAP6
  • DAXX
view

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: [email protected]

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.5.0

Last updated: April 6, 2026